Saudi Arabia Advances Cancer Care with Potential Approval of Multikine Immunotherapy
- Posted on June 2, 2025
- By International Business Times
- 2 Views
Saudi Arabia Advances Cancer Care with Potential Approval of Multikine Immunotherapy
The US-based biotech company has submitted an application to the Saudi Food and Drug Authority (SFDA) for Breakthrough Medicine Designation, a fast-track regulatory pathway that could make Multikine available to patients as early as this summer.
